Overview of Thomas Kean's Trading Activity
Recent records show that Representative Thomas Kean has been active in the stock market, notably selling shares of Johnson & Johnson (NYSE: JNJ). Reports indicate that Kean's sale of JNJ stock was valued between $31,003 and $115,000, with the transaction executed on July 31, 2025. This transaction highlights the ongoing trading activities of members of Congress.
The Current State of Johnson & Johnson Stock
As of now, the shares of Johnson & Johnson are trading at approximately $179.13, reflecting a minor upward shift of 0.16%. This price movement could be influenced by a variety of market factors, including broader economic trends and company-specific events.
Recent Trading Patterns by Thomas Kean
Over the past three years, Thomas Kean has completed 105 trades, amassing a total transaction value exceeding $427,000. Significant recent transactions include purchases and sales in high-profile companies such as Johnson & Johnson and Stryker (NYSE: SYK). The following details some of his key trades:
Highlighted Transactions
- Johnson & Johnson (JNJ): Sold shares valued between $15,001 and $50,000.
- Stryker (SYK): Sold shares valued between $15,001 and $50,000.
- Check Point Software (NASDAQ: CHKP): Purchased shares valued between $15,001 and $50,000.
The Importance of Monitoring Congressional Trades
Why do these transactions matter? Congressional trading activity sheds light on the financial dealings of those in power. When a representative buys or sells stocks, it can serve as a hint about their expectations for a company's performance. While these trades shouldn't be the sole basis for investment decisions, they can be an informative data point for investors.
Legislation Affecting Disclosure of Trades
In April 2012, former President Obama enacted the STOCK Act, which mandates that members of Congress must publicly disclose their transactions within a specific timeframe. This legislation aims to prevent insiders from exploiting non-public information for personal financial gain, thus promoting transparency.
Why Understanding These Trends Is Crucial
Investors should consider congressional transactions as one piece of the puzzle when evaluating potential investments. A new purchase by a congressperson might suggest a belief that the stock will increase in value. Conversely, a sale can occur for many reasons and should not be interpreted solely as a lack of confidence in the stock's future performance.
Frequently Asked Questions
What stocks has Rep. Thomas Kean recently traded?
Rep. Thomas Kean has recently traded stocks including Johnson & Johnson, Stryker, and Check Point Software.
What is the significance of the STOCK Act?
The STOCK Act requires congressional members to disclose their stock trades promptly to prevent insider trading based on non-public information.
What does a sale of stock by a congressperson imply?
A sale can imply various motivations, such as portfolio rebalancing or liquidity needs, and does not necessarily indicate that the stock will decrease in value.
How often does Rep. Thomas Kean trade stocks?
In the past three years, Rep. Thomas Kean has executed over 100 trades, reflecting an active trading strategy.
What was the recent trading volume for Johnson & Johnson?
Currently, Johnson & Johnson shares are trading at approximately $179.13 and have seen a slight increase.
